The estimated Net Worth of John Choma is at least $343 millier dollars as of 1 July 2009. John Choma owns over 312 units of Omnicell stock worth over $323,111 and over the last 19 years John sold OMCL stock worth over $19,441.
John has made over 13 trades of the Omnicell stock since 2007, according to the Form 4 filled with the SEC. Most recently John sold 312 units of OMCL stock worth $3,354 on 1 July 2009.
The largest trade John's ever made was exercising 8,000 units of Omnicell stock on 7 February 2007 worth over $134,960. On average, John trades about 3,141 units every 55 days since 2005. As of 1 July 2009 John still owns at least 7,502 units of Omnicell stock.
You can see the complete history of John Choma stock trades at the bottom of the page.
John's mailing address filed with the SEC is C/O OMNICELL, INC., 1201 CHARLESTON ROAD, MOUNTAIN VIEW, CA, 94043.
Over the last 21 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps et Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.
since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice
Omnicell executives and other stock owners filed with the SEC include: